László G. Hársing

3.3k total citations
138 papers, 2.7k citations indexed

About

László G. Hársing is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Biochemistry. According to data from OpenAlex, László G. Hársing has authored 138 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 83 papers in Cellular and Molecular Neuroscience, 65 papers in Molecular Biology and 14 papers in Biochemistry. Recurrent topics in László G. Hársing's work include Neuroscience and Neuropharmacology Research (66 papers), Neurotransmitter Receptor Influence on Behavior (30 papers) and Receptor Mechanisms and Signaling (29 papers). László G. Hársing is often cited by papers focused on Neuroscience and Neuropharmacology Research (66 papers), Neurotransmitter Receptor Influence on Behavior (30 papers) and Receptor Mechanisms and Signaling (29 papers). László G. Hársing collaborates with scholars based in Hungary, United States and France. László G. Hársing's co-authors include E. Sylvester Vizi, Péter Mátyus, György Lévay, Michael J. Zigmond, Gábor Szénási, Ábel Lajtha, Henry Sershen, Zsolt Jurányi, István Gacsályi and Gábor Gigler and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Gastroenterology and Brain Research.

In The Last Decade

László G. Hársing

135 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
László G. Hársing Hungary 30 1.6k 1.2k 311 285 226 138 2.7k
Yutaka Gomita Japan 27 1.3k 0.8× 775 0.6× 330 1.1× 426 1.5× 230 1.0× 236 2.7k
Soumen Paul United States 24 1.6k 0.9× 983 0.8× 229 0.7× 321 1.1× 421 1.9× 48 2.7k
Hans O. Kalkman Switzerland 30 1.7k 1.0× 1.8k 1.5× 592 1.9× 211 0.7× 199 0.9× 68 3.6k
Michael F. Mazurek Canada 30 2.0k 1.2× 1.3k 1.1× 546 1.8× 257 0.9× 199 0.9× 56 3.4k
Matthew P. Galloway United States 35 1.9k 1.2× 1.2k 1.0× 362 1.2× 520 1.8× 399 1.8× 86 3.5k
Malika El Yacoubi France 24 1.5k 0.9× 1.3k 1.0× 330 1.1× 285 1.0× 369 1.6× 41 3.3k
P. Slater United Kingdom 30 2.2k 1.3× 1.2k 1.0× 521 1.7× 499 1.8× 107 0.5× 134 3.1k
Yukihiro Ohno Japan 32 2.0k 1.2× 1.2k 1.0× 345 1.1× 206 0.7× 102 0.5× 129 3.3k
Sharon C. Cheetham United Kingdom 29 1.5k 0.9× 845 0.7× 440 1.4× 328 1.2× 216 1.0× 70 2.8k
L. Charles Murrin United States 35 2.6k 1.6× 2.1k 1.7× 505 1.6× 392 1.4× 207 0.9× 80 4.1k

Countries citing papers authored by László G. Hársing

Since Specialization
Citations

This map shows the geographic impact of László G. Hársing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by László G. Hársing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites László G. Hársing more than expected).

Fields of papers citing papers by László G. Hársing

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by László G. Hársing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by László G. Hársing. The network helps show where László G. Hársing may publish in the future.

Co-authorship network of co-authors of László G. Hársing

This figure shows the co-authorship network connecting the top 25 collaborators of László G. Hársing. A scholar is included among the top collaborators of László G. Hársing based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with László G. Hársing. László G. Hársing is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Al‐Khrasani, Mahmoud, Imre Boldizsár, Kornél Király, et al.. (2025). Do vitamins halt the COVID-19-evoked pro-inflammatory cytokines involved in the development of neuropathic pain?. Biomedicine & Pharmacotherapy. 189. 118346–118346. 1 indexed citations
2.
Boldizsár, Imre, et al.. (2024). Glycine Transporter 1 Inhibitors: Predictions on Their Possible Mechanisms in the Development of Opioid Analgesic Tolerance. Biomedicines. 12(2). 421–421. 4 indexed citations
3.
Balogh, Mihály, Ferenc Zádor, Zoltán Zádori, et al.. (2021). Pharmacological Evidence on Augmented Antiallodynia Following Systemic Co-Treatment with GlyT-1 and GlyT-2 Inhibitors in Rat Neuropathic Pain Model. International Journal of Molecular Sciences. 22(5). 2479–2479. 14 indexed citations
4.
Hársing, László G.. (2016). Glycine transporter 1 inhibitors may exert neuroprotective effects in hypoxic retina. 4(Suppl. 3). A1.19–A1.19. 1 indexed citations
5.
6.
Hársing, László G., et al.. (2012). Interactions between glycine transporter type 1 (GlyT-1) and some inhibitor molecules — Glycine transporter type 1 and its inhibitors (Review). Acta Physiologica Hungarica. 99(1). 1–17. 14 indexed citations
7.
Simon, Ágnes, Júlia Visy, László Héja, et al.. (2008). Cyclothiazide binding to the GABAA receptor. Neuroscience Letters. 439(1). 66–69. 3 indexed citations
8.
Gigler, Gábor, Gábor Szénási, György Lévay, et al.. (2007). Neuroprotective effect of L-kynurenine sulfate administered before focal cerebral ischemia in mice and global cerebral ischemia in gerbils. European Journal of Pharmacology. 564(1-3). 116–122. 72 indexed citations
9.
Kalló, Imre, Erik Hrabovszky, Zsolt Jurányi, et al.. (2007). Immunohistochemical and in situ hybridization studies on glycine transporter 1 after transient ischemia in the rat forebrain. Neurochemistry International. 52(4-5). 799–808. 5 indexed citations
10.
Szénási, Gábor, Tamás Szabó, Mihály Albert, et al.. (2007). 2,3-Benzodiazepine-type AMPA receptor antagonists and their neuroprotective effects. Neurochemistry International. 52(1-2). 166–183. 34 indexed citations
11.
Papp, András, Zsolt Jurányi, László Nagymajtényi, Péter Mátyus, & László G. Hársing. (2007). The synaptic and nonsynaptic glycine transporter type-1 inhibitors Org-24461 and NFPS alter single neuron firing rate in the rat dorsal raphe nucleus. Neurochemistry International. 52(1-2). 130–134. 12 indexed citations
12.
Hársing, László G., et al.. (2006). Glycine Transporter Type-1 and its Inhibitors. Current Medicinal Chemistry. 13(9). 1017–1044. 60 indexed citations
13.
Gigler, Gábor, et al.. (2004). Comparison of the AMPA Antagonist Action of New 2,3-Benzodiazepines in Vitro and Their Neuroprotective Effects in Vivo. Pharmaceutical Research. 21(2). 317–323. 13 indexed citations
14.
Hársing, László G. & Michael J. Zigmond. (1997). Influence of dopamine on GABA release in striatum: evidence for D1–D2 interactions and non-synaptic influences. Neuroscience. 77(2). 419–429. 99 indexed citations
15.
Sershen, Henry, Audrey Hashim, László G. Hársing, & Ábel Lajtha. (1991). Chronic nicotine-induced changes in dopaminergic system: Effect on behavioral response to dopamine agonist. Pharmacology Biochemistry and Behavior. 39(2). 545–547. 7 indexed citations
16.
17.
Rosivall, László, et al.. (1979). Intrarenal distribution of renal blood flow in the rat.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 53(4). 389–97. 4 indexed citations
18.
Selmeci, L., et al.. (1979). Hypertrophic response of the kidney in indomethacin treated rats.. PubMed. 53(4). 427–32. 1 indexed citations
19.
Fazekas, Á, E. Pósch, & László G. Hársing. (1978). [Studying the regional blood flow in the tongue of the dog by the H2 gas wash-out technic].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 71(7). 207–10. 1 indexed citations
20.
Rosivall, László, et al.. (1978). Effect on intrarenal circulation of sympathetic vasoconstrictor inhibition.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 51(4). 343–51. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yutaka Gomita Breakdown of academic impact, for papers by Soumen Paul Breakdown of academic impact, for papers by Hans O. Kalkman Breakdown of academic impact, for papers by Michael F. Mazurek Breakdown of academic impact, for papers by Matthew P. Galloway Breakdown of academic impact, for papers by Malika El Yacoubi Breakdown of academic impact, for papers by P. Slater Breakdown of academic impact, for papers by Yukihiro Ohno Breakdown of academic impact, for papers by Sharon C. Cheetham Breakdown of academic impact, for papers by L. Charles Murrin
Rankless by CCL
2026